Can-fite Biopharma Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Jul. 29, 2024).

Can-Fite Biopharma Ltd., a biopharmaceutical company, has filed a Form 6-K with the U.S. Securities and Exchange Commission (SEC). The filing contains information required to be made public in the company's domicile country and is not considered "filed" for liability purposes. The SEC filing is a formal document or financial statement submitted by publicly-traded companies. For more information on the filing, readers can visit the SEC's website. [Extracted from the article]